Viridian Therapeutics Grants Stock Options to New Employees
Viridian Therapeutics Inc. has granted non-qualified stock options for 88,300 shares to four new employees. The exercise price is set at the closing price on the grant date, November 3, 2025. The options will vest over four years, with 25% vesting on the first anniversary and the remainder in 36 monthly installments, contingent on continued employment.
Viridian Therapeutics Inc. has approved the grant of non-qualified stock options to purchase a total of 88,300 shares of company common stock for four new employees. The stock options will have an exercise price equal to the closing price of Viridian’s common stock on the grant date, November 3, 2025. The options vest over four years, with 25% vesting on the first anniversary of the employee’s start date and the remainder vesting in 36 equal monthly installments, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viridian Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251107767864) on November 07, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
